Blue Owl Capital Inc. Valuation Multiples

Discover Blue Owl Capital Inc.'s revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Janus Living, Zheshang Securities, Dongxing Securities, Remgro and more.

Blue Owl Capital Inc. Overview

About Blue Owl Capital Inc.

Blue Owl Capital Inc is one of the world's key alternative-asset managers with over $307 billion in assets under management, specializing in providing capital solutions to middle-market companies, private equity firms, and real estate owners. The firm operates three primary platforms: Credit, GP Strategic Capital, and Real Assets, offering direct lending, minority stake acquisitions in asset managers, and net lease real estate solutions. The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.


Founded

2020

HQ

United States

Employees

1.4K

Financials (LTM)

Revenue: $2.8B
EBITDA: $1.6B

EV

$11B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Blue Owl Capital Inc. Financials

Blue Owl Capital Inc. reported last 12-month revenue of $2.8B and EBITDA of $1.6B.

In the same LTM period, Blue Owl Capital Inc. generated $1.6B in EBITDA and $1.3B in net income.

Revenue (LTM)


Blue Owl Capital Inc. P&L

In the most recent fiscal year, Blue Owl Capital Inc. reported revenue of $2.9B and EBITDA of $1.5B.

Blue Owl Capital Inc. is profitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 53%, and net margin of 46%.

See analyst estimates for Blue Owl Capital Inc.
LTMLast FY202320242025202620272028
Revenue$2.8B$2.9B$1.7B$2.3B$2.9B
Gross Profit-$1.6B$861M$1.3B$1.6B
Gross Margin-54%50%56%54%
EBITDA$1.6B$1.5B$633M$866M$894M
EBITDA Margin57%53%37%38%31%
EBIT Margin51%51%18%26%16%
Net Profit$1.3B$1.3B$54M$110M$79M
Net Margin45%46%3%5%3%
Net Debt-$3.1B---

Financial data powered by Morningstar, Inc.

Blue Owl Capital Inc. Stock Performance

Blue Owl Capital Inc. has current market cap of $6.4B, and enterprise value of $11B.

Market Cap Evolution


Blue Owl Capital Inc.'s stock price is $9.52.

Blue Owl Capital Inc. share price increased by 8.8% in the last 30 days, and decreased by 50.8% in the last year.

Blue Owl Capital Inc. has an EPS (earnings per share) of $1.94.

See more trading valuation data for Blue Owl Capital Inc.
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$11B$6.4B0.0%8.8%-2.4%-50.8%$1.94

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Blue Owl Capital Inc. Valuation Multiples

Blue Owl Capital Inc. trades at 3.9x EV/Revenue multiple, and 6.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Blue Owl Capital Inc.

EV / Revenue (LTM)


Blue Owl Capital Inc. Financial Valuation Multiples

As of July 19, 2026, Blue Owl Capital Inc. has market cap of $6.4B and EV of $11B.

Blue Owl Capital Inc. has a P/E ratio of 5.1x.

LTMLast FY202320242025202620272028
EV/Revenue3.9x3.7x6.1x4.6x3.7x
EV/EBITDA6.8x7.0x16.8x12.2x11.9x
EV/EBIT7.5x7.2x33.4x17.5x23.2x
EV/Gross Profit-6.8x12.3x8.3x6.8x
P/E5.1x4.9x118.4x58.7x81.6x
EV/FCF94.8x8.8x12.0x11.3x8.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Blue Owl Capital Inc. Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Blue Owl Capital Inc. Margins & Growth Rates

Blue Owl Capital Inc. decreased revenue by 1% but EBITDA grew by 6% in the last fiscal year.

In the most recent fiscal year, Blue Owl Capital Inc. reported gross margin of 54%, EBITDA margin of 53%, and net margin of 46%.

See estimated margins and future growth rates for Blue Owl Capital Inc.

Blue Owl Capital Inc. Margins

Last FY202420252026202720282029
Gross Margin54%56%54%-
EBITDA Margin53%38%31%57%
EBIT Margin51%26%16%48%
Net Margin46%5%3%43%
FCF Margin42%41%42%4%

Blue Owl Capital Inc. Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(1%)33%25%(1%)
Gross Profit Growth-48%22%-
EBITDA Growth6%37%3%80%
EBIT Growth(8%)91%(25%)198%
Net Profit Growth(8%)102%(28%)1425%
FCF Growth(91%)6%28%(91%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Blue Owl Capital Inc. Operational KPIs

Blue Owl Capital Inc.'s revenue per employee in the last FY averaged $2.1M, while opex per employee averaged $0.8M for the same period.

Blue Owl Capital Inc.'s Rule of 40 is 56% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Blue Owl Capital Inc.'s Rule of X is 53% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Blue Owl Capital Inc.
LTMLast FY202320242025202620272028
Rule of 4066%56%---
Bessemer Rule of X80%53%---
Revenue per Employee-$2.1M---
Opex per Employee-$0.8M---
G&A Expenses to Revenue13%26%14%18%26%
Opex to Revenue45%39%31%29%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Blue Owl Capital Inc. Competitors

Blue Owl Capital Inc. competitors include Janus Living, Zheshang Securities, Dongxing Securities, Remgro, Gecina, Zhongtai Securities, Alliance Witan, Covivio, SDIC Capital and Aedifica.

Most Blue Owl Capital Inc. public comparables operate across Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Janus Living8.5x8.2x30.8x30.8x
Zheshang Securities11.4x10.6x--
Dongxing Securities16.0x---
Remgro1.8x-21.5x-
Gecina14.4x17.0x20.2x20.5x
Zhongtai Securities9.4x9.0x--
Alliance Witan21.8x---
Covivio11.1x22.0x11.3x24.2x

This data is available for Pro users. Sign up to see all Blue Owl Capital Inc. competitors and their valuation data.

Start Free Trial

Acquisitions by Blue Owl Capital Inc.

Blue Owl Capital Inc. has acquired 13 companies to date.

Last acquisition by Blue Owl Capital Inc. was on April 19th 2026. Blue Owl Capital Inc. acquired Sila Realty Trust for $2.4B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Blue Owl Capital Inc.

Sila Realty Trust
Interos
Coremont
South Reach Networks
Description
Sila Realty Trust Inc is a real estate investment trust. Its investment objective is to pay regular cash distributions to stockholders and to preserve, protect, and return capital contributions to stockholders. The company owns and manages healthcare assets. The company generates revenue from real estate investments in healthcare properties.
Interos is an Arlington-headquartered provider of AI-powered supply chain risk management software serving U.S. federal agencies and Fortune 500 enterprises. The platform aggregates data from over 300 sources to deliver ecosystem mapping, supplier risk scoring, and continuous monitoring for third-party risks including geopolitical, financial, and ESG factors. Deployed by clients like Lockheed Martin and the Department of Defense, Interos enables predictive analytics to enhance supply chain resiliency. Founded in 2005, the company processes billions of commercial relationships annually.
Coremont delivers web-based portfolio management technology and outsourced investment operations services to asset managers and financial institutions.
South Reach Networks is a Tampa-based telecommunications provider building fiber optic infrastructure in Florida. The company owns and operates metro networks in Hillsborough and Pinellas Counties, alongside carrier-neutral data centers in St. Petersburg and Clearwater. Services include dark fiber leasing, wavelength services, and colocation for enterprises and hyperscalers.
HQ CountryUnited StatesUnited StatesUnited KingdomUnited States
HQ City
-
Washington, DC
-
Miami, FL
Deal Date19 Apr 20266 Jan 20263 Dec 202515 Jul 2025
Valuation$2.4Bundisclosed$40Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Blue Owl Capital Inc. acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Blue Owl Capital Inc.

Blue Owl Capital Inc. has invested in 28 companies to date.

Latest investment by Blue Owl Capital Inc. was on July 14th 2026. Blue Owl Capital Inc. invested in BlackFin Capital Partners in their Undisclosed stage round.

See VC round multiples

Latest Investments by Blue Owl Capital Inc.

BlackFin Capital Partners
Cleveland Cavaliers
Ambrosia Biosciences
Atlas Holdings
Description
BlackFin Capital Partners is a private equity firm targeting asset-light financial services companies across Europe. Paris-headquartered since 2012, it manages over 2 billion euros in assets under management and pursues buy-and-build strategies in payments, insurance brokerage, and asset management. The firm has executed more than 20 platform investments, including leading European loan servicers and fintech platforms, while supporting portfolio growth through operational enhancements and add-on acquisitions in markets from France to Germany.
Cleveland Cavaliers, also known as the Cavs, are an American professional basketball team based in Cleveland, Ohio.
Ambrosia Biosciences is a contract research organization providing drug development services focused on small molecule therapies for obesity, diabetes, and metabolic disorders.
Atlas Holdings is a Greenwich, Connecticut-headquartered industrial holding company that owns and operates businesses in building materials, packaging, pulp and paper, steel, energy, and logistics sectors. It manages over 20 manufacturing and distribution companies worldwide, focusing on operational turnarounds and value creation in complex industries.
HQ CountryFranceUnited StatesUnited StatesUnited States
HQ City
Paris
Cleveland, OH
Boulder, CO
Greenwich, CT
Deal Date14 Jul 20265 Jul 202630 Mar 20269 Mar 2026
RoundUndisclosed stageUndisclosed stageSeries BUndisclosed stage
Raisedundisclosedundisclosed$100Mundisclosed
InvestorsBlue Owl Capital Inc.Blue Owl Capital Inc.Boulder Ventures; Blue Owl Capital Inc.; Redmile Group; Biotechnology Value Fund; Deep Track Capital; Janus Henderson Investors; Samsara BioCapitalBlue Owl Capital Inc.; Blackstone
Valuationundisclosed$5.5Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Blue Owl Capital Inc. investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Blue Owl Capital Inc.

When was Blue Owl Capital Inc. founded?Blue Owl Capital Inc. was founded in 2020.
Where is Blue Owl Capital Inc. headquartered?Blue Owl Capital Inc. is headquartered in United States.
How many employees does Blue Owl Capital Inc. have?As of today, Blue Owl Capital Inc. has over 1K employees.
Who is the CEO of Blue Owl Capital Inc.?Blue Owl Capital Inc.'s CEO is Marc S. Lipschultz.
Is Blue Owl Capital Inc. publicly listed?Yes, Blue Owl Capital Inc. is a public company listed on NYSE.
What is the stock symbol of Blue Owl Capital Inc.?Blue Owl Capital Inc. trades under OWL ticker.
When did Blue Owl Capital Inc. go public?Blue Owl Capital Inc. went public in 2021.
Who are competitors of Blue Owl Capital Inc.?Blue Owl Capital Inc. main competitors include Janus Living, Zheshang Securities, Dongxing Securities, Remgro, Gecina, Zhongtai Securities, Alliance Witan, Covivio, SDIC Capital, Aedifica.
What is the current market cap of Blue Owl Capital Inc.?Blue Owl Capital Inc.'s current market cap is $6.4B.
What is the current revenue of Blue Owl Capital Inc.?Blue Owl Capital Inc.'s last 12 months revenue is $2.8B.
What is the current revenue growth of Blue Owl Capital Inc.?Blue Owl Capital Inc. revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Blue Owl Capital Inc.?Current revenue multiple of Blue Owl Capital Inc. is 3.9x.
What is the current EBITDA of Blue Owl Capital Inc.?Blue Owl Capital Inc.'s last 12 months EBITDA is $1.6B.
What is Blue Owl Capital Inc.'s EBITDA margin?Blue Owl Capital Inc.'s last 12 months EBITDA margin is 57%.
What is the current EV/EBITDA multiple of Blue Owl Capital Inc.?Current EBITDA multiple of Blue Owl Capital Inc. is 6.8x.
What is the current FCF of Blue Owl Capital Inc.?Blue Owl Capital Inc.'s last 12 months FCF is $112M.
What is Blue Owl Capital Inc.'s FCF margin?Blue Owl Capital Inc.'s last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Blue Owl Capital Inc.?Current FCF multiple of Blue Owl Capital Inc. is 94.8x.
How many companies Blue Owl Capital Inc. has acquired to date?As of July 2026, Blue Owl Capital Inc. has acquired 13 companies.
What was the largest acquisition by Blue Owl Capital Inc.?$2.4B acquisition of Sila Realty Trust on 19th April 2026 was the largest M&A Blue Owl Capital Inc. has done to date.
What companies Blue Owl Capital Inc. acquired?Blue Owl Capital Inc. acquired Sila Realty Trust, IPI Partners, Oak Street Real Estate Capital, Kuvare Asset Management (KAM), Atalaya Capital, Prima Capital Advisors, Wellfleet Credit Partners, Coremont, Ascentium Group, Blue Owl Technology Finance Corp. II, and 3 other companies.
In how many companies Blue Owl Capital Inc. has invested to date?As of July 2026, Blue Owl Capital Inc. has invested in 28 companies.
What was the last Blue Owl Capital Inc. investment?On 14th July 2026 Blue Owl Capital Inc. invested in BlackFin Capital Partners, participating in a Undisclosed stage round.
In what companies Blue Owl Capital Inc. invested in?Blue Owl Capital Inc. invested in Crusoe AI Data Center, Big Brand Tire & Service, Nscale, AlphaSense, MapLight Therapeutics, Cardurion Pharmaceuticals, Mirador Therapeutics, Aviceda Therapeutics, 6sense, Windward Bio, Electra Therapeutics, Vestwell, TORL BioTherapeutics, Allica Bank, Latigo Biotherapeutics, Alterome Therapeutics, Juniper Square, CloudPay, Lycia Therapeutics, Ambrosia Biosciences, and 8 other companies.

See public comps similar to Blue Owl Capital Inc.

Lists including Blue Owl Capital Inc.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial